Senior insider sale
EDGEWISE THERAPEUTICS, INC. — senior position signals high conviction
$3.35M
115.47K shares
What this filing means
EDRIS BADREDDIN plans to sell 115.47K shares of EDGEWISE THERAPEUTICS, INC. valued at approximately $3.35M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/21/2026ACC: 0001968582-26-000043
Director
Since Mar 2021
115.47K
Shares to sell
$3.35M
Approx. market value
115.47K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
1/21/2026
115.47KTotal acquired115.47K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/21/2026 | Stock Option Exercise Cash | 115.47K | — |
| Total | 115.47K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
115.47K
Market value
$3.35M
1/21/2026
Total
Units
115.47K
Value
$3.35M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/21/2026 | 115.47K | $3.35M | Nasdaq | Planned |
| Total | 115.47K | $3.35M | ||